2(1H)-Pyrimidinone, 4-amino-1-arabinofuranosyl-
147-94-4Nc1ccn(C2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1UHDGCWIWMRVCDJ-STUHELBRSA-NSee also: Cytarabine (annotation moved to); Cytarabine Hydrochloride (annotation moved to); Arabinan (annotation moved to).
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
용도Cytarabine USP (Cytosar)is used to treat Acute granulocytic leukemia (adults); acute lymphocytic leukemia (children); Hodgkin’s disease
일반 설명Cytarabine is a pyrimidine nucleoside drug that is related toidoxuridine. This agent is primarily used as an anticanceragent for Burkitt lymphoma and myeloid and lymphaticleukemias. Cytarabine blocks the cellular utilization of deoxycytidine,hence inhibiting the replication of viral DNA.Before it becomes active, the drug is converted to monophosphates,diphosphates, and triphosphates, which block DNApolymerase and the C-2 reductase that converts cytidinediphosphate into the deoxy derivative. The antiviral use of cytarabine is in the treatment of herpeszoster (shingles), herpetic keratitis, and viral infectionsthat resist idoxuridine. Cytarabine is usually administeredtopically. Toxicity occurs on bone marrow, the gastrointestinal(GI) tract, and the kidneys.
정의ChEBI: A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N1-glycosidic bond.
147-94-4、3083-52-1DTXSID60953028CHEMBL605037A white or almost white, crystalline powder, freely soluble in water, very slightly soluble in alcohol and in methylene chloride.